Treatment Discontinuation, Adherence, and Real-World Effectiveness Among Patients Treated with Ledipasvir/Sofosbuvir in the United States

INTRODUCTION: Ledipasvir/sofosbuvir (LDV/SOF) for hepatitis C virus (HCV) treatment provides an oral interferon-free treatment regimen with high rates of sustained virologic response (SVR). This study assessed treatment discontinuation, factors associated with treatment completion, and real-world ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Puenpatom, Amy, Hull, Michael, McPheeters, Jeffrey, Schwebke, Kay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595777/
https://www.ncbi.nlm.nih.gov/pubmed/28677020
http://dx.doi.org/10.1007/s40121-017-0163-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595777/
https://www.ncbi.nlm.nih.gov/pubmed/28677020
http://dx.doi.org/10.1007/s40121-017-0163-0

Ejemplares similares